相关实验视频

Updated: Aug 13, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

早期阶段3级子宫内膜状子宫内膜腺癌的全面分子特征

Han T Cun¹, Laurence Bernard², Karin Teien Lande³

¹Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago, Chicago, USA.

Gynecologic oncology

|August 10, 2024

概括

阶段IB 3级子宫内膜内膜腺癌的分子概况显示出显著的多样性. 突变特征SBS5与复发风险有关,这表明子宫内膜癌的个性化治疗策略.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
分子病理学分子病理学

背景情况:

阶段IB 3级子宫内膜内膜腺癌会带来治疗挑战.
分子特征对于确定辅助疗法策略至关重要.
了解瘤的分子特征可以指导个性化医疗.

研究的目的:

为了描述IB级3期子宫内膜状子宫内膜腺癌的分子特征.
评估ProMisE分类,突变特征和常见突变.
为了将分子发现与患者复发和治疗结果相关联.

主要方法:

包括46名患有IB级3期子宫内膜内膜腺癌的患者.
在FFPE组织上进行了免疫组织化学和整个外体序列测序.
使用个人癌症基因组报告器用于变异注释和COSMIC用于突变签名.

主要成果:

鉴定了分子多样化的瘤,尽管具有相似的组织学,阶段和等级.
在21.7%的患者中发现了POLE突变,在39.1%的患者中发现了MMR缺乏.
观察到突变特征SBS5与复发风险增加 (19.6%总体) 之间的相关性.
经常发生突变的基因包括ARID1A (65%),PTEN (61%),MUC16 (59%) 和PIK3CA (54%).

结论:

在IB级3期子宫内膜内膜腺癌中发现了分子多样化的瘤.
突变特征SBS5与更高的复发风险有关.
精细的分类和分子分析可以改善患者分层和对子宫内膜癌的个性化治疗.

关键词:

这是子宫内膜癌的癌症.分子分类的分子分类.突变的签名突变的签名根据ProMisE的分类.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...